According to Komei Diagnostics, revenue for the third quarter of 2026 was 88.1321 million yuan, down 8.39% year on year; net profit attributable to shareholders of listed companies was 10.6701 million yuan, down 38.04% year on year; after deducting non-net profit of 7.1652 million yuan, down 50.94% year on year. Revenue for the first three quarters of 2026 was 243 million yuan, down 6.99% year on year; net profit attributable to shareholders of listed companies was 26.2063 million yuan, down 36.95% year on year; after deducting non-net profit of 167.313 million yuan, down 45.19% year on year.

According to Komei Diagnostics, revenue for the third quarter of 2026 was 88.1321 million yuan, down 8.39% year on year; net profit attributable to shareholders of listed companies was 10.6701 million yuan, down 38.04% year on year; after deducting non-net profit of 7.1652 million yuan, down 50.94% year on year. Revenue for the first three quarters of 2026 was 243 million yuan, down 6.99% year on year; net profit attributable to shareholders of listed companies was 26.2063 million yuan, down 36.95% year on year; after deducting non-net profit of 167.313 million yuan, down 45.19% year on year.